Discusses 3-Year Topline Results From EMBARK Phase 3 Trial of ELEVIDYS in Duchenne Muscular Dystrophy January 26, ...
Clark's seventh consecutive quarter of volume plus mix-led growth even as volume growth has been somewhat challenging to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results